Conmed Corp
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG000BFZVH8
CNMD
Conmed Corp
GICS: -
·
Sektor: EQTY
·
Sub-Sektor: Medical - Devices
NAME
Conmed Corp
ISIN
US2074101013
TICKER
CNMD
MIC
XNYS
REUTERS
CNMD
BLOOMBERG
CNMD US
F&G:
75
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 07.07.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced that Martha Aronson will be stepping down from the company’s Board of Directors to assume the role of President and Chief Executive Officer at Merit Medical, a global leader in the development, manufacture and distribution of proprietary medical devices. Mrs. Aronson’s resignation from the Board will...
Conmed Corp
Mi., 02.07.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2025 after the market close on Wednesday, July 30, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
To participate in the conference call via telephone, please click here to ...
Conmed Corp
Mi., 21.05.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025.
“LaVerne’s extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her e...
Conmed Corp
Mi., 21.05.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 20, 2025, payable on July 3, 2025, to all shareholders of record as of June 13, 2025.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures....
Conmed Corp
Mi., 30.04.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2025.
First Quarter 2025 Highlights
Sales of $321.3 million increased 2.9% year-over-year as reported and 3.8% in constant currency.
Domestic revenue increased 4.2% year-over-year.
International revenue increased 1.2% year-over-year as re...
Conmed Corp
Mi., 02.04.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2025 after the market close on Wednesday, April 30, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
To participate in the conference call via telephone, please click here to p...
Conmed Corp
Di., 25.02.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025.
“My fellow directors and I are extremely pleased to welcome Mark to the board,” said Martha Goldberg Aronson, Chair of CONMED’s Board of Directors. “Mark brings a wealth of experience to CONMED, including deep know...
Conmed Corp
Di., 25.02.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4, 2025, to all shareholders of record as of March 14, 2025.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical pr...
Conmed Corp
Mi., 05.02.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2024.
Fourth Quarter 2024 Highlights
Sales of $345.9 million increased 5.8% year over year as reported and 6.0% in constant currency.
Domestic revenue increased 6.8% year over year.
International revenue increased 4....
Conmed Corp
Mo., 06.01.2025
Conmed Corp
US2074101013
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
To participate in the conference call via telephone, please click here ...
Conmed Corp
Informationen zu Product Placements
BARRISTA SMART * AD
P R O D U C T S U G G E S T I O N S
